Effect of sertraline on ouabain-induced arrhythmia in isolated guinea-pig atria

Depression and Anxiety

Volumn 26, Issue 8, 2009, Pages

  Pousti, Abbas ^a   Bakhtiarian, Azam ^a   Najafi, Rouhallah ^a   Deemyad, Tara ^a   Brumand, Kaveh ^a   Hosseini, Mir Jamal ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Arrhythmia; Isolated atria; Ouabain; Sertraline; Toxicity

Indexed keywords

OUABAIN; SERTRALINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASYSTOLE; CHRONOTROPISM; CONTROLLED STUDY; DISSECTION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; GUINEA PIG; HEART ARRHYTHMIA; HEART ATRIUM; HEART MUSCLE CONTRACTILE FORCE; INOTROPISM; NONHUMAN; PRIORITY JOURNAL; SODIUM CALCIUM EXCHANGE;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ANTIDEPRESSIVE AGENTS; ARRHYTHMIAS, CARDIAC; CALCIUM CHANNELS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTROCARDIOGRAPHY; GUINEA PIGS; HEART ARREST; HEART ATRIA; HEART RATE; MYOCARDIAL CONTRACTION; ORGAN CULTURE TECHNIQUES; OUABAIN; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SODIUM CHANNELS;

EID: 68149128555     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20407     Document Type: Article

References (38)

1. Glassman AH, Bigger T. Cardiovascular effects of therapeutic doses of tricyclic antidepressants. Arch Gen Psychiatry 1981;38:815-820. (Pubitemid 11087242)
2. Yeragani VK, Pesce V, Jayaraman A, Roose S. Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on long-term heart rate variability measures. Biol Psychatry 2002;52:418-429. (Pubitemid 35266733)
3. Yeragani VK. Major depression and long-term heart period variability. Depress Anxiety 2000;12:51-52. (Pubitemid 30679704)
4. Pacher P, Kohegyi E, Kecskemeti V, Furst S. Current trends in the development of new antidepressants. Curr Med Chem 2001;8:89-100. (Pubitemid 32409768)
5. Pacher P, Kecskemeti V. Trends in the development of new antidepressants. Is there a light at the end of the tunnel? Curr Med Chem 2004;11:925-943.
6. Otaga N, Narahashi T. Block of sodium channels by psychotropic drugs in single guinea-pig cardiac myocytes. Br J Pharmacol 1989;97:905-913. (Pubitemid 19168726)
7. Pacher P, Kecskemeti V, Ungvari Z, Korom S, Pankucsi C. Cardiodepressant effects of fluoxetine in isolated heart preparations. Naunyn-Schmeideberg's Arch Pharmacol 1998;358(Suppl 2):R641.
8. Pacher P, Ungvari Z, Kecskemeti V, Frust S. Review of cardiovascular effects of fluoxetine, a selective serotonin reuptake inhibitor, compared to tricyclic antidepressants. Curr Med Chem 1998;5:381-390. (Pubitemid 28470789)
9. 2+ channel opener. Stroke 1999;30:1949-1954.
10. 2+ sensitivity. Br J Pharmacol 1999;127:740-746.
11. Pacher P, Ungvari Z, Nanasi PP, Frust S, Kecskmeti V. Speculations on difference between tricyclic and selective serotonin reuptake inhibitor antidepressants on their cardiac effects. Is there any? Curr Med Chem 1999;66:469-480.
12. Pacher P, Magyar J, Szigligeti P, Banyasz T, Pankucsi C, Korom Z, Ungvari Z, Kecskemeti V, Nanasi PP. Electrophysiological effects of fluoxetine in mammalian cardiac tissues. Naunyn Schmiedebergs Arch Pharmacol 2000;361:67-73. (Pubitemid 30064656)
13. Pacher P, Magyar J, Szigligeti P, Banyasz T, Pankucsi C, Korom Z, Ungvari Z, Kecskemeti V, Nanasi PP. Cardiac electrophysiological effects of citalopram in guinea pig papillary muscle comparison with clomipramine. Gen Pharmacol 2000;34:17-23. (Pubitemid 30227665)
14. Pacher P, Ungvari Z, Kecskemeti V, Friedmann T, Furst S. Serotonin reuptake inhibitors fluoxetine and citalopram relax intestinal smooth muscle. Can J Physiol Pharmacol 2001;79:580-584. (Pubitemid 32747867)
15. Pacher P, Kecskemeti V. Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? Curr Pharm Des 2004;10:2463-2475. (Pubitemid 38997427)
16. Pacher P, Ungvari Z. Selective serotonin-reuptake inhibitor antidepressants increase the risk of falls and hip fractures in elderly people by inhibiting cardiovascular ion channels. Medical Hypotheses 2001;57:469-471. (Pubitemid 33052038)
17. Ungvari Z, Pacher P, Koller A. Serotonin reuptake inhibitor fluoxetine decreases arteriolar myogenic tone by reducing smooth muscle [Ca2+]i. J Cardiovasc Pharmacol 2000;36:849-854. (Pubitemid 30327512)
18. Ozyavuz R, Kalyoncu NI, Karaoglu S. Long-term use of sertraline leads to alterations in contractility of rat isolated vas deferens. Urol Res 2003;32:20-24. (Pubitemid 38314140)
19. Shores MM, Pascualy M, Lewis NL, Flatness D, Veith RC. Short-term sertraline treatment suppresses sympathetic nervous system activity in healthy human subjects. Psychoneuroendocrinology 2001;26:433-439. (Pubitemid 32222947)
20. Siepmann M, Grossmann J, Muck-Weymann M, Kirch W. Effect of sertraline on autonomic and cognitive functions in healthy volunteers. Psychopharmacology 2003;168:293-298. (Pubitemid 36920912)
21. Sullivan GM, Kent JM, Kleber M, Martinez JM, Yeragani VK, Gorman JM. Effects of hyperventilation on heart rate and QT variability in panic disorder pre- and post-treatment. Psychiatry Res 2004;125:29-39. (Pubitemid 38210250)
22. Pousti A, Malihi G, Naghibi B. Effect of citalopram on ouabaininduced arrhythmia in isolated guinea-pig atria. Hum Psychopharmacol Clin Exp 2003;18:121-124. (Pubitemid 36304726)
23. Pousti A, Malihi G, Abdollahi M, Toosi ER. The effect of fluoxetine on ouabain-induced arrhythmia in isolated guinea-pig atria. Indian J Pharmacol 2003;35:55-58. (Pubitemid 36187476)
24. Pousti A, Deemyad T, Brumand K, Bakhtiarian A. The effect of fluvoxamine on ouabain-induced arrhythmia in isolated guineapig atria. Pharmacol Res 2005;52:151-153. (Pubitemid 40828365)
25. Deak F, Lasztoczi B, Pacher P, Petheo GL, Kecskemeti, V, Spat A. Inhibition of voltage-gated calcium channel by fluoxetine in rat hippocampal pyramidal cells. Neuropharmacology 2000;39:1029-1036. (Pubitemid 30155710)
26. Magyar J, Rusznak Z, Harasztosi C, Kortvely A, Pacher P, Banyasz T, Pankucsi C, Kovacs L, Szucs G, Nanasi PP, Kecskmeti V. Differential effects of fluoxetine enantiomers in mammalian neural and cardiac tissues. Int J Mol Med 2003;11:535-542.
27. Yeragani VK, Pohl R, Jampala VC, Balon R, Ramesh C, Srinivasan K. Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder. Depress Anxiety 2000;11:126-130. (Pubitemid 30347189)
28. Zareba W, Moss AJ, le Cessie S. Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease. Am J Cardiol 1994;74:550-553. (Pubitemid 24279934)
29. Roose SP, Miyazaki M. Pharmacologic treatment of depression in patients with heart disease. Psycosomat Med 2005;67:54-57. (Pubitemid 40721034)
30. Yeragani VK, Pohl R, Jampala VC, Balon R, Ramesh C, Srinivasan K. Increased QT variability in patients with panic disorder and depression. Psychiatry Res 2000;93:225-235. (Pubitemid 30175953)
31. Becker B, Morel N, Vanbellinghen AM, Lebrun P. Blockade of calcium entry in smooth muscle cells by the antidepressant imipramine. Biochem Pharmacol 2004;68:833-842. (Pubitemid 39044512)
32. 2+ mobilization in platelets. Eur J Pharmacol 1995;290:173-174.
33. Medina P, Segarra G, Ballester R, Chuan P, Domenech C, Vila JM, Lluch S. Effects of antidepressants in adrenergic neurotransmission of human vas deferens. Urology 2000;55:592-597. (Pubitemid 30157977)
34. + currents in rat ventricular myocytes. Yonsei Med J 1999;40:144-151.
35. Kalyoncu NI, Ozyavuz R, Karaoglu S. Sertraline inhibits the contractile responses to noradrenaline, KCl and electrical field stimulation of rat isolated vas deferens. J Auton Pharmacol 1999;19:365-369. (Pubitemid 30616159)
36. Brenner GM. Pharmacology, 1st edition. USA: WB Saunders Co; 2000:115.
37. Katzung BG. Basic & Clinical Pharmacology, 9th edition. USA: McGraw-Hill; 2004:93.
38. Bigger T, Giardina E, Perel JM, Kantor S, Glassman A. Cardiac antiarrhythmic effect of imipramine HCl. New Engl J Med 1977;266:206-208. (Pubitemid 8031210)